SMNROTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SMNRW
Semnur Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.43+0.03 (+6.75%)
Close on Oct 19, 2026
- Market cap
- $98.30M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.5730 (−95.26%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $98.30M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$167.68M
- EPS, diluted
- -$0.83
- Book value per share
- -$0.13
- Diluted shares
- 230M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
-$167.55M
Net income
-$167.68M
EPS, diluted
-$0.83
Reported periodTrailing twelve months